Literature DB >> 16153625

Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome.

Ching-Wan Lam1, Yuet-Ping Yuen, Wai-Fun Cheng, Yan-Wo Chan, Sui-Fan Tong.   

Abstract

BACKGROUND: Chylomicronemia syndrome can be caused by 2 autosomal recessive disorders - lipoprotein lipase (LPL) deficiency and apolipoprotein C-II (apo C-II) deficiency.
METHODS: We described 2 siblings with chylomicronemia syndrome of a consanguineous family. To determine the molecular basis of chylomicronemia syndrome in this family, we performed direct DNA sequencing of the LPL and APOC2 genes of the proband.
RESULTS: A novel homozygous mutation, Leu72Pro, in the APOC2 gene was found in both siblings whereas their parents were carriers. No LPL mutations were detected in the siblings. Apo C-II contains 3 amphipathic alpha helices; the C-terminal alpha helix is composed of residues 64 to 74. Substitution of residue 72 from a helix former leucine to a helix breaker, proline, is predicted to change the secondary structure of the C-terminal helix and subsequently alter the interaction between apo C-II and LPL.
CONCLUSIONS: To our knowledge, Leu72Pro is the first missense mutation identified in the C-terminal of apo C-II. The result is consistent with the current biochemical and structural findings that the C-terminal helix of apo C-II is important for activation of LPL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153625     DOI: 10.1016/j.cca.2005.07.025

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

Review 1.  Chylomicronaemia--current diagnosis and future therapies.

Authors:  Amanda J Brahm; Robert A Hegele
Journal:  Nat Rev Endocrinol       Date:  2015-03-03       Impact factor: 43.330

2.  Aldo-keto Reductase 1B15 (AKR1B15): a mitochondrial human aldo-keto reductase with activity toward steroids and 3-keto-acyl-CoA conjugates.

Authors:  Susanne Weber; Joshua K Salabei; Gabriele Möller; Elisabeth Kremmer; Aruni Bhatnagar; Jerzy Adamski; Oleg A Barski
Journal:  J Biol Chem       Date:  2015-01-10       Impact factor: 5.157

Review 3.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

4.  Site-directed mutagenesis of apolipoprotein CII to probe the role of its secondary structure for activation of lipoprotein lipase.

Authors:  Yan Shen; Aivar Lookene; Liyang Zhang; Gunilla Olivecrona
Journal:  J Biol Chem       Date:  2009-12-30       Impact factor: 5.157

Review 5.  Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia.

Authors:  L Renee Ruhaak; Arnoud van der Laarse; Christa M Cobbaert
Journal:  Ann Clin Biochem       Date:  2019-03-19       Impact factor: 2.057

Review 6.  Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia.

Authors:  György Paragh; Ákos Németh; Mariann Harangi; Maciej Banach; Péter Fülöp
Journal:  Lipids Health Dis       Date:  2022-02-10       Impact factor: 3.876

7.  A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis.

Authors:  Jingjing Jiang; Yuhui Wang; Yan Ling; Abudurexiti Kayoumu; George Liu; Xin Gao
Journal:  Lipids Health Dis       Date:  2016-01-16       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.